Analyst Price Targets — GRPH
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 3, 2023 8:23 am | — | Morgan Stanley | $3.00 | $2.18 | Benzinga | Morgan Stanley Maintains Equal-Weight on Graphite Bio, Lowers Price Target to $3 |
| January 6, 2023 8:00 am | — | RBC Capital | $4.00 | $3.06 | Benzinga | RBC Capital Maintains Sector Perform on Graphite Bio, Lowers Price Target to $4 |
| January 6, 2023 6:27 am | — | Leerink Partners | $2.00 | $3.06 | Benzinga | SVB Leerink Downgrades Graphite Bio to Market Perform, Lowers Price Target to $2 |
| January 6, 2023 5:04 am | — | BMO Capital | $7.00 | $3.06 | Benzinga | BMO Capital Downgrades Graphite Bio to Market Perform, Lowers Price Target to $7 |
| July 15, 2022 10:51 am | — | Morgan Stanley | $6.00 | $3.30 | Benzinga | Morgan Stanley Maintains Equal-Weight on Graphite Bio, Lowers Price Target to $6 |
No recent news available for GRPH.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for GRPH.
U.S. House Trading
No House trades found for GRPH.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.